A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function
Clinical trial NCT05718258 · COMPLETED
Trial details
- NCT number
- NCT05718258
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2024-01-29
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.